Genpharmasec Statistics

Total Valuation

Genpharmasec has a market cap or net worth of INR 730.91 million. The enterprise value is 789.74 million.

Market Cap	730.91M
Enterprise Value	789.74M

Important Dates

The last earnings date was Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Genpharmasec has 553.72 million shares outstanding. The number of shares has decreased by -25.74% in one year.

Current Share Class	553.72M
Shares Outstanding	553.72M
Shares Change (YoY)	-25.74%
Shares Change (QoQ)	-63.34%
Owned by Insiders (%)	45.21%
Owned by Institutions (%)	n/a
Float	289.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.74
PB Ratio	1.11
P/TBV Ratio	1.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-172.36
EV / Sales	0.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.04

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-4.89%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	0.51%
Revenue Per Employee	98.52M
Profits Per Employee	-458,200
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Genpharmasec has paid 657,000 in taxes.

Income Tax	657,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.33% in the last 52 weeks. The beta is -0.84, so Genpharmasec's price volatility has been lower than the market average.

Beta (5Y)	-0.84
52-Week Price Change	-38.33%
50-Day Moving Average	1.29
200-Day Moving Average	1.77
Relative Strength Index (RSI)	57.00
Average Volume (20 Days)	1,540,312

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genpharmasec had revenue of INR 985.18 million and -4.58 million in losses. Loss per share was -0.01.

Revenue	985.18M
Gross Profit	71.46M
Operating Income	-34.98M
Pretax Income	-12.85M
Net Income	-4.58M
EBITDA	-29.07M
EBIT	-34.98M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 50.38 million in cash and 110.13 million in debt, with a net cash position of -59.74 million or -0.11 per share.

Cash & Cash Equivalents	50.38M
Total Debt	110.13M
Net Cash	-59.74M
Net Cash Per Share	-0.11
Equity (Book Value)	655.87M
Book Value Per Share	1.12
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 7.25%, with operating and profit margins of -3.55% and -0.47%.

Gross Margin	7.25%
Operating Margin	-3.55%
Pretax Margin	-1.30%
Profit Margin	-0.47%
EBITDA Margin	-2.95%
EBIT Margin	-3.55%
FCF Margin	n/a

Dividends & Yields

Genpharmasec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	25.74%
Shareholder Yield	25.74%
Earnings Yield	-0.63%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 11, 2019. It was a forward split with a ratio of 10.

Last Split Date	Apr 11, 2019
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a